Literature DB >> 13035719

The formation of thromboplastin in human blood.

R BIGGS, A S DOUGLAS, R G MACFARLANE.   

Abstract

Entities:  

Keywords:  THROMBOPLASTIC SUBSTANCES

Mesh:

Substances:

Year:  1953        PMID: 13035719      PMCID: PMC1393042          DOI: 10.1113/jphysiol.1953.sp004830

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  7 in total

1.  Platelets and the coagulation defect caused by dicumarol.

Authors:  F D MANN; M HURN; N W BARKER
Journal:  Am J Clin Pathol       Date:  1951-09       Impact factor: 2.493

2.  The anti-coagulants in blood and serum.

Authors:  B J Collingwood; M T Macmahon
Journal:  J Physiol       Date:  1912-09-11       Impact factor: 5.182

3.  Co-thromboplastin, a probable factor in coagulation of blood.

Authors:  F D Mann; M Hurn
Journal:  Am J Physiol       Date:  1951-01

4.  Experiments on a new clotting factor (factor VII).

Authors:  F KOLLER; A LOELIGER; F DUCKERT
Journal:  Acta Haematol       Date:  1951       Impact factor: 2.195

5.  Enzyme studies on human blood. XI. The isolation and characterization of thromboplastic cell and plasma components.

Authors:  G Y SHINOWARA
Journal:  J Lab Clin Med       Date:  1951-07

6.  Thrombasthenia and thrombocytopenic purpura; report of case demonstrating qualitative and quantitative inadequacy of platelets.

Authors:  B ALEXANDER; G LANDWEHR
Journal:  N Engl J Med       Date:  1949-12-15       Impact factor: 91.245

7.  Thrombopathic thrombocytopenia; successful transfusion of blood platelets.

Authors:  E O HIRSCH; J FAVRE-GILLY; W DAMESHEK
Journal:  Blood       Date:  1950-06       Impact factor: 22.113

  7 in total
  22 in total

1.  [ACTIVATION OF BLOOD COAGULATION BY A BACTERIAL ENDOTOXIN IN PERSONS UNDER COUMARIN THERAPY].

Authors:  M H HOERDER; R MANRIQUE
Journal:  Klin Wochenschr       Date:  1965-04-01

Review 2.  [THE STUART-PROWER FACTOR: ITS COAGULATION PHYSIOLOGY AND CLINICAL SIGNIFICANCE].

Authors:  V HIEMEYER; M H HOERDER
Journal:  Klin Wochenschr       Date:  1964-11-15

3.  [Studies on a third plasma factor in thromboplastin formation].

Authors:  F K BELLER; E MAMMEN
Journal:  Klin Wochenschr       Date:  1955-02-15

4.  [Differential diagnosis of congenital Stuart factor deficiency].

Authors:  M H HORDER
Journal:  Klin Wochenschr       Date:  1959-04-15

5.  [Blood coagulation disorder in hyperheparinemia].

Authors:  H H SESSNER; L ROKA; E CHRISTMANN
Journal:  Klin Wochenschr       Date:  1960-10-15

6.  Platelet phosphatides: their separation, identification, and clotting activity.

Authors:  A J MARCUS; T H SPAET
Journal:  J Clin Invest       Date:  1958-12       Impact factor: 14.808

7.  Inactivation of thromboplastin in human blood.

Authors:  T H SPAET; E S GARNER
Journal:  J Clin Invest       Date:  1955-12       Impact factor: 14.808

8.  The action of heparin in the prevention of prothrombin conversion.

Authors:  A S DOUGLAS
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

9.  The blood clotting factors in human saliva.

Authors:  F NOUR-ELDIN; J F WILKINSON
Journal:  J Physiol       Date:  1957-04-30       Impact factor: 5.182

10.  ERRORS in diagnosis of cardiac infarction.

Authors: 
Journal:  Br Med J       Date:  1958-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.